Advertisement
Screener

Insight Molecular Diagnostics Inc. (IMDX) Increase (Decrease) in Accounts Payable and Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

Insight Molecular Diagnostics Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities

Insight Molecular Diagnostics Inc. (IMDX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$1.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-10

  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$1.10M.
  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$105.00K, a 110.22% decline year-over-year.
  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $3.56M, a 404.97% increase year-over-year.
  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $1.18M, a 81.36% increase year-over-year.
  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $2.65M, a 173.63% increase from fiscal 2024.
  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $967.00K.
  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$4.76M, a 1701.68% decline from fiscal 2022.
  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $297.00K.
Period endIncrease (Decrease) in Accounts Payable and Accrued Liabilities 3 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 6 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 9 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed
2026-06-30-$1.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
-$1.21M
10-Q · filed 2026-08-10
$2.35M
derived: sum of 3 quarters · filed 2026-08-10
$3.52M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31-$105.00K
10-Q · filed 2026-05-13
$3.45M
derived: sum of 2 quarters · filed 2026-05-13
$4.63M
derived: sum of 3 quarters · filed 2026-05-13
$1.51M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31$3.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$4.73M
derived: sum of 2 quarters · filed 2026-03-26
$1.62M
derived: sum of 3 quarters · filed 2026-08-10
$2.65M
10-K · filed 2026-03-26
2025-09-30$1.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$1.94M
derived: sum of 2 quarters · filed 2026-08-10
-$909.00K
10-Q · filed 2025-11-10
-$205.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30-$3.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
-$2.09M
10-Q · filed 2026-08-10
-$1.38M
derived: sum of 3 quarters · filed 2026-08-10
-$733.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31$1.03M
10-Q · filed 2026-05-13
$1.73M
derived: sum of 2 quarters · filed 2026-05-13
$2.38M
derived: sum of 3 quarters · filed 2026-05-13
$1.14M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$704.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$1.35M
derived: sum of 2 quarters · filed 2026-03-26
$113.00K
derived: sum of 3 quarters · filed 2026-03-26
$967.00K
10-K · filed 2026-03-26
2024-09-30$649.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$591.00K
derived: sum of 2 quarters · filed 2025-11-10
$263.00K
10-Q · filed 2025-11-10
-$301.00K
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30-$1.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
-$386.00K
10-Q · filed 2025-08-11
-$950.00K
derived: sum of 3 quarters · filed 2025-08-11
-$824.00K
derived: sum of 4 quarters · filed 2025-08-11
2024-03-31$854.00K
10-Q · filed 2025-05-12
$290.00K
derived: sum of 2 quarters · filed 2025-05-12
$416.00K
derived: sum of 3 quarters · filed 2025-05-12
-$1.24M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31-$564.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24
-$438.00K
derived: sum of 2 quarters · filed 2025-03-24
-$2.10M
derived: sum of 3 quarters · filed 2025-03-24
-$4.76M
10-K · filed 2025-03-24
2023-09-30$126.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$1.53M
derived: sum of 2 quarters · filed 2024-11-12
-$4.19M
10-Q · filed 2024-11-12
-$4.32M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$1.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$4.32M
10-Q · filed 2024-08-08
-$4.44M
derived: sum of 3 quarters · filed 2024-08-08
-$4.26M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$2.66M
10-Q · filed 2024-05-15
-$2.79M
derived: sum of 2 quarters · filed 2024-05-15
-$2.60M
derived: sum of 3 quarters · filed 2024-05-15
-$2.34M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$125.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
$58.00K
derived: sum of 2 quarters · filed 2024-04-16
$318.00K
derived: sum of 3 quarters · filed 2024-04-16
$297.00K
10-K · filed 2024-04-16
2022-09-30$183.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$443.00K
derived: sum of 2 quarters · filed 2023-11-09
$422.00K
10-Q · filed 2023-11-09
$666.00K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$260.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$239.00K
10-Q · filed 2023-08-10
$483.00K
derived: sum of 3 quarters · filed 2023-08-10
-$343.00K
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$21.00K
10-Q · filed 2023-05-15
$223.00K
derived: sum of 2 quarters · filed 2023-05-15
-$603.00K
derived: sum of 3 quarters · filed 2023-05-15
-$1.77M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$244.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12
-$582.00K
derived: sum of 2 quarters · filed 2023-04-12
-$1.75M
derived: sum of 3 quarters · filed 2023-04-12
-$1.35M
10-K · filed 2023-04-12
2021-09-30-$826.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
-$2.00M
derived: sum of 2 quarters · filed 2022-11-10
-$1.59M
10-Q · filed 2022-11-10
-$2.59M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$1.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
-$766.00K
10-Q · filed 2022-08-12
-$1.76M
derived: sum of 3 quarters · filed 2022-08-12
-$982.00K
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$405.00K
10-Q · filed 2022-05-12
-$590.00K
derived: sum of 2 quarters · filed 2022-05-12
$189.00K
derived: sum of 3 quarters · filed 2022-05-12
$6.00K
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$995.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
-$216.00K
derived: sum of 2 quarters · filed 2022-03-11
-$399.00K
derived: sum of 3 quarters · filed 2022-03-11
$848.00K
10-K · filed 2022-03-11
$854.00K
10-K · filed 2021-03-19
2020-09-30$779.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$596.00K
derived: sum of 2 quarters · filed 2021-11-09
$1.84M
10-Q · filed 2021-11-09
$3.00M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30-$183.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
$1.06M
10-Q · filed 2021-08-11
$2.22M
derived: sum of 3 quarters · filed 2021-08-11
$1.04M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$1.25M
10-Q · filed 2021-05-17
$2.40M
derived: sum of 2 quarters · filed 2021-05-17
$1.22M
derived: sum of 3 quarters · filed 2021-05-17
$2.46M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$1.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19
-$26.00K
derived: sum of 2 quarters · filed 2021-03-19
$1.21M
derived: sum of 3 quarters · filed 2021-03-19
$741.00K
10-K · filed 2021-03-19
2019-09-30-$1.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$52.00K
derived: sum of 2 quarters · filed 2020-11-12
-$416.00K
10-Q · filed 2020-11-12
$625.00K
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$1.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29
$767.00K
10-Q · filed 2020-07-29
$1.81M
derived: sum of 3 quarters · filed 2020-07-29
$1.77M
derived: sum of 4 quarters · filed 2020-07-29
2019-03-31-$468.00K
10-Q · filed 2020-05-12
$573.00K
derived: sum of 2 quarters · filed 2020-05-12
$533.00K
derived: sum of 3 quarters · filed 2020-05-12
-$465.00K
derived: sum of 4 quarters · filed 2020-05-12
2018-12-31$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
$1.00M
derived: sum of 2 quarters · filed 2020-03-26
$3.00K
derived: sum of 3 quarters · filed 2020-03-26
$1.00M
10-K · filed 2020-03-26
2018-09-30-$40.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
-$1.04M
derived: sum of 2 quarters · filed 2019-11-14
-$39.00K
10-Q · filed 2019-11-14
-$314.00K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30-$998.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$1.00K
10-Q · filed 2019-08-14
-$274.00K
derived: sum of 3 quarters · filed 2019-08-14
-$108.00K
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$999.00K
10-Q · filed 2019-05-14
$724.00K
derived: sum of 2 quarters · filed 2019-05-14
$890.00K
derived: sum of 3 quarters · filed 2019-05-14
$851.00K
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31-$275.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
-$109.00K
derived: sum of 2 quarters · filed 2019-04-01
-$148.00K
derived: sum of 3 quarters · filed 2019-04-01
-$48.00K
10-K · filed 2019-04-01
2017-09-30$166.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
$127.00K
derived: sum of 2 quarters · filed 2018-11-13
$227.00K
10-Q · filed 2018-11-13
-$92.00K
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$39.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
$61.00K
10-Q · filed 2018-08-14
-$258.00K
derived: sum of 3 quarters · filed 2018-08-14
$580.00K
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$100.00K
10-Q · filed 2018-05-15
-$219.00K
derived: sum of 2 quarters · filed 2018-05-15
$619.00K
derived: sum of 3 quarters · filed 2018-05-15
$514.00K
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$319.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$519.00K
derived: sum of 2 quarters · filed 2018-04-02
$414.00K
derived: sum of 3 quarters · filed 2018-04-02
$229.00K
10-K · filed 2018-04-02
2016-09-30$838.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$733.00K
derived: sum of 2 quarters · filed 2017-11-14
$548.00K
10-Q · filed 2017-11-14
$1.31M
derived: sum of 4 quarters · filed 2018-04-02
2016-06-30-$105.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
-$290.00K
10-Q · filed 2017-08-14
$477.00K
derived: sum of 3 quarters · filed 2018-04-02
$768.00K
derived: sum of 4 quarters · filed 2018-04-02
2016-03-31-$185.00K
10-Q · filed 2017-04-28
$582.00K
derived: sum of 2 quarters · filed 2018-04-02
$873.00K
derived: sum of 3 quarters · filed 2018-04-02
$1.05M
derived: sum of 4 quarters · filed 2018-04-02
2015-12-31$767.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$1.06M
derived: sum of 2 quarters · filed 2018-04-02
$1.23M
derived: sum of 3 quarters · filed 2018-04-02
$1.04M
10-K · filed 2018-04-02
2015-09-30$291.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$467.00K
derived: sum of 2 quarters · filed 2016-11-10
$275.00K
10-Q · filed 2016-11-10
2015-06-30$176.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
-$16.00K
10-Q · filed 2016-08-11
2015-03-31-$192.00K
10-Q · filed 2016-05-16
2014-12-31$291.00K
10-K · filed 2017-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92